Literature DB >> 27926588

Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.

Remo Minini1, Sabine Rohrmann, Ralph Braun, Dimitri Korol, Silvia Dehler.   

Abstract

The aims of this paper are to describe the incidence trends of invasive cutaneous melanoma in the Canton of Zurich and to evaluate clinical and pathological factors such as cancer subtype, localization, age and Breslow thickness. A retrospective analysis was carried out with data from the population-based Cancer Registry of Zurich and Zug located in Zurich. A total of 8469 cases in 8034 different patients of invasive cutaneous melanoma were registered for the period 1980-2010 in the Canton of Zurich. Incidence trends were age standardized to the European standard population. Joinpoint regression was used to compute changes in incidence and mortality rates, measured as the annual percent change (APC). The most common subtypes of cutaneous melanoma were superficial spreading melanoma (SSM, 41.1%), followed by nodular melanoma (16.5%), lentigo maligna melanoma (13.5%), acral-lentiginous melanoma (5.0%) and other types of melanoma (2.8%); 21.1% were melanoma not otherwise specified. The trunk was the most frequent location (30.8%), followed by the lower limb and hip (26.4%) and the upper limb and shoulder (22.8%). Statistically significantly increasing incidence trends were observed for both men (APC=3.0%) and women (APC=2.1%). Incidences of SSM and melanoma not otherwise specified were the histological subtypes for which a significant increase in incidence was observed (APC for the period 1980-2010=3.2% for both). In terms of Breslow thickness, thin melanomas (0.01-1.00 mm) showed an increasing incidence. The incidence of melanoma increased in both men and women between 1980 and 2010. In terms of the different subtypes and Breslow thickness, increasing incidences of the SSM and of thin melanomas (0.01-1.00 mm) were observed. These observations are in agreement with other studies from Southern and Western Switzerland as well as other European countries and the USA.

Entities:  

Mesh:

Year:  2017        PMID: 27926588     DOI: 10.1097/CMR.0000000000000312

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  11 in total

1.  Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study.

Authors:  J Rubió-Casadevall; M Puig-Vives; M Puigdemont; L Vilardell; A Carbó-Bagué; R Marcos-Gragera; N Vilar-Coromina
Journal:  Clin Transl Oncol       Date:  2018-06-05       Impact factor: 3.405

2.  Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.

Authors:  Clio Dessinioti; Niki Dimou; Alan C Geller; Aravella Stergiopoulou; Serigne Lo; Ulrike Keim; Jeffrey E Gershenwald; Lauren E Haydu; Simone Ribero; Pietro Quaglino; Susana Puig; Josep Malvehy; Lidija Kandolf-Sekulovic; Tatjana Radevic; Roland Kaufmann; Laura Meister; Eduardo Nagore; Victor Traves; Grigorios G Champsas; Mihaela Plaka; Brigitte Dreno; Emilie Varey; David Moreno Ramirez; Reinhard Dummer; Joanna Mangana; Axel Hauschild; Friederike Egberts; Ketty Peris; Laura Del Regno; Ana-Maria Forsea; Sabina A Zurac; Ricardo Vieira; Ana Brinca; Iris Zalaudek; Teresa Deinlein; Eleni Linos; Evangelos Evangelou; John F Thompson; Richard A Scolyer; Claus Garbe; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

3.  Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.

Authors:  Shirin Bajaj; Douglas Donnelly; Melissa Call; Paul Johannet; Una Moran; David Polsky; Richard Shapiro; Russell Berman; Anna Pavlick; Jeffrey Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

4.  Association of Skin Examination Behaviors and Thinner Nodular vs Superficial Spreading Melanoma at Diagnosis.

Authors:  Clio Dessinioti; Alan C Geller; Aravella Stergiopoulou; Susan M Swetter; Eszter Baltas; Jonathan E Mayer; Timothy M Johnson; John Talaganis; Myrto Trakatelli; Dimitrios Tsoutsos; Gerasimos Tsourouflis; Alexander J Stratigos
Journal:  JAMA Dermatol       Date:  2018-05-01       Impact factor: 10.282

5.  RNAi-mediated IARS2 knockdown inhibits proliferation and promotes apoptosis in human melanoma A375 cells.

Authors:  Dongmei Ma; Song Li; Xiaojuan Nie; Lamei Chen; Nan Chen; Dongsheng Hou; Xiuhong Liu; Binbin Gao
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

6.  High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types.

Authors:  Ville Suhonen; Jaana Rummukainen; Hanna Siiskonen; Arto Mannermaa; Ilkka T Harvima
Journal:  BMC Cancer       Date:  2021-10-29       Impact factor: 4.430

7.  Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria.

Authors:  Sebastian Haferkamp; Christian Apfelbacher; Konstantin Drexler; Hans Drexler; Edward K Geissler; Mark Berneburg
Journal:  Adv Ther       Date:  2021-10-01       Impact factor: 3.845

8.  Alpha-Enolase (ENO1) Correlates with Invasiveness of Cutaneous Melanoma-An In Vitro and a Clinical Study.

Authors:  Miriam Hippner; Michal Majkowski; Przemyslaw Biecek; Teresa Szkudlarek; Aleksandra Simiczyjew; Malgorzata Pieniazek; Dorota Nowak; Arkadiusz Miazek; Piotr Donizy
Journal:  Diagnostics (Basel)       Date:  2022-01-20

Review 9.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

Review 10.  Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland.

Authors:  Miriam Wanner; Katarina L Matthes; Dimitri Korol; Silvia Dehler; Sabine Rohrmann
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.